HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $11,128,000 | – | 13,000,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 116,032,000 | $131,460,000 | 5.04% |
| Worth Venture Partners, LLC | 3,505,000 | $3,986,000 | 2.22% |
| CSS LLC/IL | 16,617,000 | $18,825,000 | 1.13% |
| SSI INVESTMENT MANAGEMENT LLC | 8,998,000 | $10,199,000 | 0.85% |
| Sonora Investment Management, LLC | 4,900,000 | $5,559,000 | 0.68% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,000,000 | $27,233,000 | 0.60% |
| DLD Asset Management, LP | 13,500,000 | $15,339,000 | 0.56% |
| Empyrean Capital Partners, LP | 10,000,000 | $11,344,000 | 0.52% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 13,000 | $11,991,000 | 0.35% |
| Lion Point Capital, LP | 3,000,000 | $3,411,000 | 0.31% |